c-Myc Rabbit Polyclonal Antibody
Catalog# 0912-2
c-Myc Rabbit Polyclonal Antibody
-
WB
-
Human
-
unconjugated
Overview
Product Name
c-Myc Rabbit Polyclonal Antibody
Antibody Type
Rabbit Polyclonal Antibody
Immunogen
Synthetic peptide within human C-myc aa 390-439.
Species Reactivity
Human
Validated Applications
WB
Molecular Weight
Predicted band size: 49 kDa
Positive Control
Myc-tagged recombinant protein, A549 cell lysate, Raji cell lysate.
Conjugation
unconjugated
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Immunogen affinity purified.
Application Dilution
-
WB
-
1:500
Target
Function
Myc is a family of regulator genes and proto-oncogenes that code for transcription factors. The Myc family consists of three related human genes: c-myc (MYC), l-myc (MYCL), and n-myc (MYCN). c-myc (also sometimes referred to as MYC) was the first gene to be discovered in this family, due to homology with the viral gene v-myc. In cancer, c-myc is often constitutively (persistently) expressed. This leads to the increased expression of many genes, some of which are involved in cell proliferation, contributing to the formation of cancer. A common human translocation involving c-myc is critical to the development of most cases of Burkitt lymphoma. Constitutive upregulation of Myc genes have also been observed in carcinoma of the cervix, colon, breast, lung and stomach. Myc is thus viewed as a promising target for anti-cancer drugs. Unfortunately, Myc possesses several features that render it undruggable such that any anti-cancer drugs for Myc dysregulation will require acting on the protein indirectly, i.e. targeting the mRNA for the protein rather than a small molecule that targets the protein itself. In the human genome, C-myc is located on chromosome 8 and is believed to regulate expression of 15% of all genes through binding on enhancer box sequences (E-boxes). In addition to its role as a classical transcription factor, N-myc may recruit histone acetyltransferases (HATs). This allows it to regulate global chromatin structure via histone acetylation.
Background References
1. "A quantitative atlas of mitotic phosphorylation."Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008)
2. "Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62."Gupta S., Seth A., Davis R.J. Proc. Natl. Acad. Sci. U.S.A. 90:3216-3220(1993)
Post-translational Modification
Phosphorylated by PRKDC. Phosphorylation at Ser-329 by PIM2 leads to the stabilization of MYC (By similarity). Phosphorylation at Ser-62 by CDK2 prevents Ras-induced senescence. Phosphorylated at Ser-62 by DYRK2; this primes the protein for subsequent phosphorylation by GSK3B at Thr-58. Phosphorylation at Thr-58 and Ser-62 by GSK3 is required for ubiquitination and degradation by the proteasome.; Ubiquitinated by the SCF(FBXW7) complex when phosphorylated at Thr-58 and Ser-62, leading to its degradation by the proteasome. In the nucleoplasm, ubiquitination is counteracted by USP28, which interacts with isoform 1 of FBXW7 (FBW7alpha), leading to its deubiquitination and preventing degradation. In the nucleolus, however, ubiquitination is not counteracted by USP28 but by USP36, due to the lack of interaction between isoform 3 of FBXW7 (FBW7gamma) and USP28, explaining the selective MYC degradation in the nucleolus. Also polyubiquitinated by the DCX(TRUSS) complex. Ubiquitinated by TRIM6 in a phosphorylation-independent manner (By similarity).
Subcellular Location
Nucleus.
UNIPROT
Synonyms
AU016757 antibody
Avian myelocytomatosis viral oncogene homolog antibody
bHLHe39 antibody
c Myc antibody
Class E basic helix-loop-helix protein 39 antibody
MRTL antibody
Myc antibody
Myc protein antibody
Myc proto oncogene protein antibody
Myc proto-oncogene protein antibody
ExpandAU016757 antibody
Avian myelocytomatosis viral oncogene homolog antibody
bHLHe39 antibody
c Myc antibody
Class E basic helix-loop-helix protein 39 antibody
MRTL antibody
Myc antibody
Myc protein antibody
Myc proto oncogene protein antibody
Myc proto-oncogene protein antibody
myc-related translation/localization regulatory factor antibody
MYC_HUMAN antibody
Myc2 antibody
MYCC antibody
Myelocytomatosis oncogene antibody
Niard antibody
Nird antibody
Oncogene Myc antibody
OTTHUMP00000158589 antibody
Proto-oncogene c-Myc antibody
Protooncogene homologous to myelocytomatosis virus antibody
RNCMYC antibody
Transcription factor p64 antibody
Transcriptional regulator Myc-A antibody
V-Myc avian myelocytomatosis viral oncogene homolog antibody
v-myc myelocytomatosis viral oncogene homolog (avian) antibody
CollapseImages
-
Western blot analysis on myc-tagged recombinant protein (A) and A549 cell lysates (B).
-
Western blot analysis of c-Myc on different lysates with Rabbit anti-c-Myc antibody (0912-2) at 1/1,000 dilution.
Lane 1: A549 cell lysate
Lane 2: Raji cell lysate
Lysates/proteins at 10 µg/Lane.
Predicted band size: 49 kDa
Observed band size: 49 kDa
Exposure time: 2 minutes;
8% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (0912-2) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:300,000 dilution was used for 1 hour at room temperature.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Protease-mediated PRC1 dissociation promotes H2AK119ub remodeling during stress responses
Journal: EMBO Journal
DOI: 10.1038/s44318-026-00729-9
IF: 8.3
Application: CoIP
Reactivity: Human
Publish date: 2026 Mar
-
TM9SF4 acts as a receptor mediating Glaesserella parasuis cytolethal distending toxin–induced cytotoxicity in PK15 cells
Journal: Frontiers In Cellular And Infection Microbiology
DOI: 10.3389/fcimb.2026.1783709
IF: 4.8
Application: CoIP,WB
Reactivity: Human
Publish date: 2026 Mar
-
MKRN2 enhances hepatocellular carcinoma proliferation through the p38 MAPK pathway
Journal: Human Cell
DOI: 10.1007/s13577-026-01349-5
IF: 3.1
Application: WB
Reactivity: Human
Publish date: 2026 Feb
-
Covalent modification of Keap1 Cys489 by NU6300 activates Nrf2 signaling and suppresses NLRP3 inflammasome-mediated pyroptosis
Journal: Journal Of Pharmaceutical Analysis
DOI: 10.1016/j.jpha.2025.101458
IF: 8.9
Application: WB,IP,CoIP
Reactivity: Human
Publish date: 2025 Sept
-
TCF7 functions as a prognostic biomarker in bladder cancer by strengthening EMT and stemness associated with TGF-β/SMAD3 signaling
Journal: MOLECULAR AND CELLULAR BIOCHEMISTRY
DOI: 10.1007/s11010-025-05241-y
IF: 3.7
Application: WB
Reactivity: Human
Publish date: 2025 Mar
-
Drosophila aux orchestrates the phosphorylation-dependent assembly of the lysosomal V-ATPase in glia and contributes to SNCA/α-synuclein degradation
Journal: Autophagy
DOI:
IF: 14.6
Application: IHC-P,WB
Reactivity: Fly
Publish date: 2025 Jan
-
New Atg9 Phosphorylation Sites Regulate Autophagic Trafficking in Glia
Journal: ASN Neuro
DOI:
IF: 3.9
Application: WB,Pull Down
Reactivity: Drosophila
Publish date: 2025 Jan
-
Drosophila aux orchestrates the phosphorylation-dependent assembly of the lysosomal V-ATPase in glia and contributes to SNCA/α-synuclein degradation
Journal: Autophagy
DOI: 10.1080/15548627.2024.2442858
IF: 14.3
Application: IHC,WB
Reactivity: Fly
Publish date: 2025 Jan
-
New Atg9 Phosphorylation Sites Regulate Autophagic Trafficking in Glia
Journal: ASN Neuro
DOI: 10.1080/17590914.2024.2443442
IF: 3.7
Application: WB,Pull Down
Reactivity: Drosophila
Publish date: 2025 Jan
-
WWP2-induced inhibition of hepatocellular carcinoma cellular senescence via the ubiquitination and degradation of p21
Journal: Cell Death & Disease
DOI: 10.1038/s41419-025-08318-0
IF: 9.6
Application: IHC
Reactivity: Mouse
Publish date: 2025 Dec
-
Linear ubiquitination regulates the KSHV replication and transcription activator protein to control infection
Journal: Nature Communications
DOI:
IF: 14.7
Application: WB
Reactivity: Human
Publish date: 2024 Jul
-
Identification of (S)-10-Hydroxycamptothecin as a potent BRD4 inhibitor for treating triple-negative breast cancer
Journal: Journal Of Molecular Structure
DOI: 10.1016/j.molstruc.2022.133366
IF: 3.841
Application: WB
Reactivity: Human
Publish date: 2022 May
-
Metastatic Tumor Cell-Specific FABP7 Promotes NSCLC Metastasis via Inhibiting β-Catenin Degradation
Journal: Cells
DOI:
IF: 6.600
Application: IHC-P
Reactivity: Mouse
Publish date: 2022 Feb
-
Tumor Suppressor Functions of miRNA-375 in Nasopharyngeal Carcinoma through Inhibition of Ubiquitin-Specific Protease 1 Expression
Journal: International Journal Of Biochemistry And Cell Biology
DOI:
IF: 5.09
Application: WB
Reactivity: Human
Publish date: 2021 Dec
-
Case Report: 7-Ethyl-10-Hydroxycamptothecin, a DNA Topoisomerase I Inhibitor, Performs BRD4 Inhibitory Activity and Inhibits Human Leukemic Cell Growth. Frontiers in pharmacology, 12, 664176.
Journal: Frontiers In Pharmacology
DOI:
IF: 4.4
Application: WB
Reactivity: Human
Publish date: 2021 Apr
-
MORF2 tightly associates with MORF9 to regulate chloroplast RNA editing in Arabidopsis.
Journal: Plant Science
DOI:
IF: 3.712
Application: WB
Reactivity: Arabidopsis thaliana
Publish date: 2019 Jan
-
The ColRS-Regulated Membrane Protein Gene XAC1347 Is Involved in Copper Homeostasis and hrp Gene Expression in Xanthomonas citri subsp. citri
Journal: Frontiers In Microbiology
DOI:
IF: 4.019
Application: WB
Reactivity: Xanthomonas citri subsp. citri (Xcc)
Publish date: 2018 Jun
-
Rabies Virus Infection Induces Microtubule Depolymerization to Facilitate Viral RNA Synthesis by Upregulating HDAC6
Journal: Frontiers In Cellular And Infection Microbiology
DOI:
IF: 4.3
Application: WB
Reactivity: Rabies Virus
Publish date: 2017 Apr
Alternative Products
c-Myc Recombinant Rabbit Monoclonal Antibody [PS00-11]
Application: WB,IHC-P,IP,ChIP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Products with the same target and pathway
Phospho-c-Myc (T58) Recombinant Rabbit Monoclonal Antibody [SN60-01]
Application: WB,IF-Cell,IF-Tissue,FC,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
c-Myc Recombinant Rabbit Monoclonal Antibody [PS00-11]
Application: WB,IHC-P,IP,ChIP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
HRP Conjugated c-Myc Rabbit Polyclonal Antibody
Application: WB
Reactivity: Human
Conjugate: HRP
c-Myc Mouse Monoclonal Antibody [6G6]
Application: WB,IP,IF,IHC-P
Reactivity: Human,Mouse,Rat,Monkey
Conjugate: unconjugated
Phospho-c-Myc (S62) Recombinant Rabbit Monoclonal Antibody [ST49-08]
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Phospho-c-Myc (T58 + S62) Recombinant Rabbit Monoclonal Antibody [SZ02-06]
Application: WB,IP,FC
Reactivity: Human,Mouse
Conjugate: unconjugated